(Q40059831)

17 September 2017

title

TNF-alpha increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK. (English)

1 reference

17 September 2017

0 references

Isabelle Plaisance

1

1 reference

17 September 2017

Christian Morandi

series ordinal

2

1 reference

17 September 2017

Claire Murigande

series ordinal

3

1 reference

17 September 2017

Marijke Brink

series ordinal

4

1 reference

17 September 2017

publication date

30 October 2007

1 reference

American Journal of Physiology - Endocrinology and Metabolism

17 September 2017

published in

1 reference

17 September 2017

volume

294

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

E241-50

1 reference

TNF-alpha modulates cytokine and cytokine receptors in C2C12 myotubes

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Tumor necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Tumor Necrosis Factor-α Decreases Insulin-Like Growth Factor-I Messenger Ribonucleic Acid Expression in C2C12 Myoblasts via a Jun N-Terminal Kinase Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Tumor necrosis factor induces skeletal muscle protein breakdown in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

TNF-alpha induces protein synthesis through PI3-kinase-Akt/PKB pathway in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Regulation of translation initiation factors by signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Acute treatment with TNF-alpha attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

Regenerating soleus and extensor digitorum longus muscles of the rat show elevated levels of TNF-alpha and its receptors, TNFR-60 and TNFR-80.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2007

10.1152/AJPENDO.00129.2007

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference